Cancer Chemopreventive Effect of Spirogyra Neglecta (Hassall) Kützing on Diethylnitrosamine-Induced Hepatocarcinogenesis in Rats

  • Published : 2014.02.28


Spirogyra neglecta, a freshwater green alga, is a local food in the northern and northeastern parts of Thailand. This investigation explored the anticarcinogenicity of S neglecta and its possible cancer chemopreventive mechanisms in rats divided into 14 groups. Groups 1 and 10 served as positive and negative control groups, respectively. Groups 1-9 were intraperitoneally injected with diethylnitrosamine (DEN) once a week for 3 weeks. Groups 10-14 received normal saline instead. One week after the last DEN injection, groups 2-5 were administered for 9 consecutive weeks various doses of S neglecta extract (SNE) and dried S neglecta (SND), mixed with basal diet. Groups 6-9 and 11-14 similarly were administered various doses of SNE and SND starting from the first week of the experiment. Administration of SNE and SND was not associated with formation of glutathione-Stransferase placental form (GST-P) positive foci in rat liver. SNE and SND during initiation phase significantly reduced the number of GST-P positive foci in rats injected with DEN. The number of GST-P also diminished in groups treated with SNE and SND after injection with DEN, except for the low dose extract group. SNE showed stronger anticarcinogenic potency than SND. Furthermore, SNE also decreased the number of Ki-67 positive cells. However, the numbers of TUNEL-positive cells in the liver of the SNE-treated groups were not statistically different from the controls. The GST activity in 50 mg/kg bw of SNE and 1% of SND groups was significantly increased as compared to the positive control. In conclusion, Spirogyra neglecta (Hassall) K$\ddot{u}$tzing showed cancer chemopreventive properties at the early stages of diethylnitrosamine-induced hepatocarcinogenesis in rats. Possible inhibitory mechanisms include enhancement of the activities of some detoxifying enzymes and/or suppression of precancerous cells.


  1. Thumvijit T, Inboot W, Peerapornpisal Y, et al (2013a). The antimutagenic and antioxidant properties of Spirogyra neglecta (Hassall) Kutzing. J Med Plant Res, 7, 2494-500.
  2. Puatanachokchai R, Kakuni M, Wanibuchi H, et al (2006). Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGFalpha transgenic mice. Asian Pac J Cancer Prev, 7, 274-8.
  3. Smit AJ (2004). Medicinal and pharmaceutical uses of seaweed natural products: A review. J Appl Phycol, 16, 245-62.
  4. Sun SY, Hail N Jr, Lotan R (2004). Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst, 96, 662-72.
  5. Thumvijit T, Thuschana W, Amornlerdpison D, et al (2013b). Evaluation of hepatic antioxidant capacities of Spirogyra neglecta (Hassall) Kutzing in rats. Interdiscip Toxicol, 6, 101-5.
  6. Tsuda H, Fukushima S, Wanibuchi H, et al (2003). Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work. Toxicol Pathol, 31, 80-6.
  7. Tsuda H, Ohshima Y, Nomoto H, et al (2004). Cancer prevention by natural compounds. Drug Metab Pharmacokinet, 19, 245-63.
  8. Tsuda H, Futakuchi M, Fukamachi K, et al (2010). A mediumterm, rapid rat bioassay model for the detection of carcinogenic potential of chemicals. Toxicol Pathol, 38, 182-7.
  9. Wattenberg LW (1997). An overview of chemoprevention: current status and future prospects. Proc Soc Exp Biol Med, 216, 133-44.
  10. Yamazoe Y, Shimada M, Kamataki T, et al (1983). Microsomal activation of 2-amino-3-methylimidazo[4.5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate. Cancer Res, 43, 5768-74.
  11. Nobili S, Lippi D, Witort E, et al (2009). Natural compounds for cancer treatment and prevention. Pharmacol Res, 59, 365-78.
  12. Lin GY, Chen ZL, Lu CM, et al (2000). Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients. World J Gastroenterol, 6, 234-8.
  13. Muthuirulappan S, Francis SP (2013). Anti-cancer mechanism and possibility of nano-suspension formulation for a marine algae product fucoxanthin. Asian Pac J Cancer Prev, 14, 2213-6.
  14. Nakajima K, Yokoyama A, Nakajima Y (2009). Anticancer effects of a tertiary sulfonium compound, dimethylsulfoniopropionate, in green sea algae on Ehrlich ascites carcinoma-bearing mice. J Nutr Sci Vitaminol, 55, 434-8.
  15. Punvittayagul C, Pompimon W, Wanibuchi H, et al (2012). Effect of pinocembrin on the initiation and promotion stages of rat hepatocarcinogenesis. Asian Pac J Cancer Prev, 13, 2257-61.
  16. Ong TP, Heidor R, de Conti A, et al (2006). Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase. Carcinogenesis, 27, 1194-203.
  17. Ontawong A, Saowakon N, Vivithanaporn P, et al (2013). Antioxidant and renoprotective effects of Spirogyra neglecta (Hassall) Kutzing extract in experimental type 2 diabetic rats. Biomed Res Int, 820786, 1-15.
  18. Puatanachokchai R, Kishida H, Denda A, et al (2002). Inhibitory effects of lemon grass (Cymbopogon citratus, Stapf) extract on the early phase of hepatocarcinogenesis after initiation with diethylnitrosamine in male Fischer 344 rats. Cancer Lett, 183, 9-15.
  19. Charles AL, Chang CK, Wu ML, et al (2007). Studies on the expression of liver detoxifying enzymes in rats fed seaweed (Monostroma nitidum). Food Chem Toxicol, 45, 2390-6.
  20. Aslam MN, Paruchuri T, Bhagavathula N, et al (2010). A mineral-rich red algae extract inhibits polyp formation and inflammation in the gastrointestinal tract of mice on a highfat diet. Integr Cancer Ther, 9, 93-9.
  21. Attasara P, Buasom R (2011). Hospital-Based Cancer Registry. 27th ed. Bangkok, National Cancer Institute.
  22. Bursch W, Chabicovsky M, Wastl U, et al (2005). Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility. Toxicol Sci, 85, 515-29.
  23. Cornish ML, Garbary DJ (2010). Antioxidants from macroalgae: Potential applications in human health and nutrition. Algae, 25, 155-71.
  24. Ding J, Wang H (2014). Multiple interactive factors in hepatocarcinogenesis. Cancer Lett, [Epub ahead of print].
  25. Ferruzzi MG, Blakeslee J (2007). Digestion, absorption, and cancer preventative activity of dietary chlorophyll derivatives. Nutr Res, 27, 1-12.
  26. Habig WH, Jakoby WB (1981). Assays for the differentiation of glutathione-S-transferases. Methods Enzymol, 77, 398-405.
  27. John DM, Whitton BA, Brook AJ (2002). The freshwater algal flora of the British Isles. The United Kingdom at the University Press. Cambridge UK.
  28. Lee JC, Hou MF, Huang HW, et al (2013). Marine algal natural products with anti-oxidative, anti-inflammatory, and anticancer properties. Cancer Cell Int, 13, 55.

Cited by

  1. Antioxidant value and Antiproliferative Efficacy of Mitragynine and a Silane Reduced Analogue vol.15, pp.14, 2014,
  2. Aloe vera Inhibits Proliferation of Human Breast and Cervical Cancer Cells and Acts Synergistically with Cisplatin vol.16, pp.7, 2015,
  3. Preventive Effects of Spirogyra neglecta and a Polysaccharide Extract against Dextran Sodium Sulfate Induced Colitis in Mice vol.17, pp.4, 2016,
  4. Effect of Spirogyra neglecta on the early stages of 1, 2-dimethylhydrazine-induced colon carcinogenesis in rats vol.27, pp.2, 2018,